Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
Molecules · 2023
DOI: 10.3390/molecules28248064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Izabella Ryguła und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Vitiligo. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Janus kinase inhibitors, also known as JAK inhibitors, JAKinibs or JAKi, are a new group of disease-modifying drugs. They work by inhibiting enzymes involved in the transmission of information from receptors located in the cell membrane to the cell interior, specifically to the cell nucleus, thus disrupting the JAK-STAT pathway. This pathway plays a role in key cellular processes such as the immune response and cell growth. This feature is used in the treatment of patients with rheumatological, gastroenterological and hematological diseases. Recently, it has been discovered that JAK-STAT pathway inhibitors also show therapeutic potential against dermatological diseases such as atopic dermatitis, psoriasis, alopecia areata and acquired vitiligo. Studies are underway to use them in the treatment of several other dermatoses. Janus kinase inhibitors represent a promising class of drugs for the treatment of skin diseases refractory to conventional therapy. The purpose of this review is to summarize the latest knowledge on the use of JAKi in dermatological treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
- Department of Medical and Health Sciences, Collegium Medicum-Faculty of Medicine, WSB University, 41-300 Dąbrowa Górnicza, Poland.
ORCID-Profile: Izabella Ryguła, Konrad Kaminiów
Zitieren
APA
Ryguła, I., Pikiewicz, W., & Kaminiów, K. (2023). Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions. Molecules. https://doi.org/10.3390/molecules28248064
Vancouver
Ryguła I, Pikiewicz W, Kaminiów K. Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions. Molecules. 2023. doi:10.3390/molecules28248064
BibTeX
@article{Rygua2023,
author = {Ryguła, Izabella and Pikiewicz, Wojciech and Kaminiów, Konrad},
title = {Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28248064}
}
EUVIMED